bezuclastinib
cogent biosciences
['apex']
$cogt cogent biosciences presents preclinical data at aacr annual meeting highlighting precision therapy pipeline and announces initiation of part 2 of the registration-enabling apex trial with bezuclastinib in advanced systemic mastocytosis 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities